Astex, CRT, Institute of Cancer Research sign epigenetic research partnership
The collaboration, which leverages Astex’s fragment-based drug discovery platform, will focus on discovering and developing drug candidates targeting an undisclosed epigenetic target in a blood cancer. Astex president
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.